John G. Gribben

Queen Mary University of London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (11)

Matthew Collin

Professor of Haematology

Newcastle University

UNITED KINGDOM

View details

Anthony Hatswell

UNITED KINGDOM

View details

Jenny Byrne

Assoc prof of Haematology

University of Nottingham

UNITED KINGDOM

View details

Kevin Deighton

Head of Evidence & Analytics

UNITED KINGDOM

View details

Pedro Rodriguez Cutillas

Professor of Cell Signalling & Proteomics

Barts Cancer Institute

UNITED KINGDOM

View details

Emanuela Volpi

Professor

University of Westminster

UNITED KINGDOM

View details

Sattva S. Neelapu

UNITED STATES

View details

Christopher Bell

Reader (Associate Professor) in Functional Genomics & Epigenomics

Queen Mary University of London

UNITED KINGDOM

View details

Kurtis Edwards

University of Westminster

UNITED KINGDOM

View details

Kevin Rouault-Pierre

Senior Lecturer

Barts Cancer Institute

UNITED KINGDOM

View details

Sergey Krysov

Senior Lecturer

Queen Mary University of London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John G. Gribben

Research Interests

Explore related searches

Contact this professor

Articles (13)

Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT

Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk

CRISPR/dCas9 DNA methylation editing is heritable during human hematopoiesis and shapes immune progeny

Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma

Targeting the methylome to improve CLL outcome

Targeting the lysine-specific demethylase 1 rewires kinase networks and primes leukemia cells for kinase inhibitor treatment

Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma

NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma

Expression patterns of CD180 in the lymph nodes of patients with chronic lymphocytic leukaemia

To start and stop or just keep going?

Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience

Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative

Graft-versus-host disease: a case report of a rare but reversible cause of constrictive pericarditis

Collaborators (11)

Matthew Collin

Anthony Hatswell

Jenny Byrne

Kevin Deighton

Pedro Rodriguez Cutillas

Emanuela Volpi

Sattva S. Neelapu

Christopher Bell

Kurtis Edwards

Kevin Rouault-Pierre

Sergey Krysov

Make your next move.